Table 3.
Quality of life, evaluated with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (score 0–100), before and after the intervention (N = 12).
| Variables | Baseline | Postintervention | Significant |
|---|---|---|---|
| Physical functioning | 84.40 (13.43) | 89.44 (9.62) | 0.108 |
| Role functioning | 75.00 (66.67; 100.00) | 100.00 (54.17; 100.00) | 0.625 |
| Emotional functioningb | 75.00 (68.75; 89.58) | 91.67 (83.33; 100.00) | 0.004∗∗∗ |
| Cognitive functioninga | 84.72 (13.21) | 86.11 (15.62) | 0.723 |
| Social functioninga | 61.11 (25.95) | 83.33 (15.89) | 0.003∗∗∗ |
| Global health statusa | 66.66 (23.30) | 68.05 (20.66) | 0.782 |
| Fatiguea | 30.55 (26.00) | 26.85 (23.90) | 0.339 |
| Nausea/vomitingb | 0.00 (0.00; 16.67) | 8.33 (0.00; 16.67) | 0.375 |
| Painb | 8.33 (0.00; 33.33) | 0.00 (0.00; 3.33) | 1.000 |
| Dyspneab | 33.33 (0.00; 33.33) | 16.67 (0.00; 58.33) | 0.750 |
| Insomniab | 33.33 (0.00; 33.33) | 16.67 (0.00; 58.33) | 0.750 |
| Appetite lossb | 16.67 (0.00; 58.33) | 0.00 (0.00; 33.33) | 0.156 |
| Constipationb | 0.00 (0.00; 0.00) | 0.00 (0.00; 0.00) | 1.000 |
| Diarrheab | 0.00 (0.00; 25.00) | 0.00 (0.00; 33.33) | 1.000 |
| Financial problemsb | 0.00 (0.00; 25.00) | 0.00 (0.00; 25.00) | 1.000 |
∗∗∗P < 0.01.
a
Data presented as mean and standard deviation.
b
Data presented as median and interquartile range.